Mayank Bansal, CFA
Mayank Bansal is a CFA Charterholder and heads the Equity Research team at Kapitales Research, with over 5 years of experience analysing global equity markets. He leads fundamental, data-driven research combining rigorous financial analysis with macro trends.
Challenger Limited Highlights Strong FY27 Momentum Amid AU$11.80 Takeover Proposal
Highlights
Challenger Highlights Strong Financial Momentum
Challenger Limited (ASX: CGF) released its Annual General Meeting (AGM) addresses on 29 October 2026, outlining its financial achievements, expanding retirement income operations and developments surrounding a potential takeover. The company's shares traded at a current market price (CMP) of AU$11.870, representing a gain of approximately 0.935%.
Management highlighted improving business momentum, supported by growing annuity demand, strategic partnerships and a strengthened capital position.
FY26 Earnings and Shareholder Returns
Challenger reported normalised net profit after tax of AU$468 million for FY26, representing 3% annual growth. Normalised earnings per share increased 3% to 68.1 cents, while excess capital exceeded AU$1.1 billion. The company increased its fully franked ordinary dividend by 7% to 31.5 cents per share and declared an additional fully franked special dividend of 1.5 cents per share.
Challenger also completed an AU$150 million on-market share buyback, acquiring approximately 16 million shares. A subsequent buyback programme of up to AU$300 million commenced on 2 October 2026 but was paused on 19 October following the takeover approach.
FY27 Sales and Asset Growth
Challenger commenced FY27 with stronger operating activity, as first-quarter annuity sales increased 72% year-on-year to AU$2.8 billion. Overall sales climbed 52% to AU$4.4 billion, while assets under management reached AU$31.9 billion, reflecting approximately 5% quarterly growth.
The company continues targeting AU$50 billion in assets under management by 2030 through expanded retirement partnerships, institutional funding and offshore reinsurance opportunities.
Takeover Developments and Outlook
TAL Daiichi Life Australia submitted a conditional, non-binding proposal on 16 October 2026 to acquire Challenger's remaining 79.5% shares at AU$11.80 per share.
Challenger's Board considered the proposed valuation insufficient but expressed willingness to explore a potentially acceptable arrangement.
Looking ahead, retirement income demand, regulatory reforms and distribution partnerships could support further expansion. However, transaction uncertainty, market conditions and execution risks remain important considerations for shareholders.
Note- All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au